[Use these links to rapidly review the document CALCULATION OF REGISTRATION FEE Title of each class of securities Amount to be Proposed maximum Proposed maximum Amount of Class A ordinary shares, par value US$0.00001 per share 152,941,798 US$3.62 US$553,649,309 US$71,864 (1) (2) (3) (4) PROSPECTUS SU]
[Use these links to rapidly review the document CALCULATION OF REGISTRATION FEE Title of each class of securities Amount to be Proposed maximum Proposed maximum Amount of Class A ordinary shares, par value US$0.00001 per share 152,941,798 US$3.62 US$553,649,309 US$71,864 (1) (2) (3) (4) PROSPECTUS SU]
[CALCULATION OF REGISTRATION FEE (1) Amount to be (2) Proposed Maximum (2) Proposed (3) Amount of Ordinary Shares, par value $0.001 per share, 826,200 $ 25.12 $ 20,754,144.00 $ 2,515.40 ]
[CALCULATION OF REGISTRATION FEE (1) Amount to be (2) Proposed Maximum (2) Proposed (3) Amount of Ordinary Shares, par value $0.001 per share, 826,200 $ 25.12 $ 20,754,144.00 $ 2,515.40 ]
[PROSPECTUS SUPPLEMENT (To Prospectus Dated May 8, 2018) 1,986,449 Series D Preferred Shares Seaspan Corporation We will not receive any of the proceeds from the sale of these series D preferred shares by the selling security-holders. successors-in-interest, The selling security-holders identified in]
[PROSPECTUS SUPPLEMENT (To Prospectus Dated May 8, 2018) 1,986,449 Series D Preferred Shares Seaspan Corporation We will not receive any of the proceeds from the sale of these series D preferred shares by the selling security-holders. successors-in-interest, The selling security-holders identified in]
[No. 333-224288 Registration PROSPECTUS SUPPLEMENT NO. 1 (To Prospectus Dated May 8, 2018) Seaspan Corporation 40,976,535 Class A Common Shares Offered by Selling Security-holders You should read this supplement no. 1 in conjunction with the accompanying prospectus. This supplement no. 1 is qualified]
[No. 333-224288 Registration PROSPECTUS SUPPLEMENT NO. 1 (To Prospectus Dated May 8, 2018) Seaspan Corporation 40,976,535 Class A Common Shares Offered by Selling Security-holders You should read this supplement no. 1 in conjunction with the accompanying prospectus. This supplement no. 1 is qualified]
[7) Registration No. 333-204761 PROSPECTUS SUPPLEMENT Issued June 2, 2016 (To Prospectus dated June 5, 2015) 2,775,000 Shares China Biologic Products, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 2,775,000 shares of common stock. We will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is listed on]
[7) Registration No. 333-204761 PROSPECTUS SUPPLEMENT Issued June 2, 2016 (To Prospectus dated June 5, 2015) 2,775,000 Shares China Biologic Products, Inc. Common Stock The selling stockholders identified in this prospectus supplement are offering 2,775,000 shares of common stock. We will not receive any proceeds from the sale of shares by the selling stockholders. Our common stock is listed on]
